ePrints

Cancer drug development in Europe: A selection of new agents under development at the European Drug Development Network

Lookup NU author(s): Professor Alan Calvert

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

From may 99, three european leaders in anti-cancer drug development (EORTC, Cancer Research UK, SENDO) have got together to form a network of collaborating groups: the European Drug Development Network. The member organisations have all agreed to join their efforts in developing new drugs. They have acquired a great and efficient expertise in anticancer drug development covering all aspects from drug screening to refinement of trial methodology and translational research. In this paper, the most interesting drugs under development in each of the three organisations are being described and discussed.

Publication metadata

Author(s): Lacombe D, Butler-Smith A, Therasse P, Fumoleau P, Burtles S, Calvert AH, Marsoni S, Sessa C, Verweij J

Publication type: Article

Publication status: Published

Journal: Cancer Investigation

Year: 2003

Volume: 21

Issue: 1

Pages: 137-147

ISSN (print): 0735-7907

ISSN (electronic): 1532-4192

URL: http://dx.doi.org/10.1081/CNV-120016408

DOI: 10.1081/CNV-120016408

PubMed id: 12643015

Altmetrics

Share